Clinical TrialsSearch results
Number of results: 819
Other
- Coronary Artery Dysfunction After Stent Implantation and Effect of Aggressive Lipid-lowering Therapy by Statins - Role of Rho-kinase -
- Ischemic heart disease
- Kyushu University Graduate School of Medical Sciences Department of Cardiovascular Medicine
- 2007-11-15
Other
- CUARTET Study
- Metastatic Castration-sensitive Prostate Cancer
- Uemura Hirotsugu
- 2020-10-09
Other
- Cyclosporin A (Neoral) for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) requiring repetitive administration of high-dose intravenous immunoglobulin
- Chronic inflammatory demyelinating polyradiculoneuropathy
- CIDP Study Group
- 2007-04-10
Other
- Cyclosporine C0 monitoring for frequently relapsing nephrotic syndrome in children
- Frequently relapsing nephrotic syndrome in children
- Japanese Study Group of Renal Disease in Children
- 2005-08-01
Other
- Cyclosporine C2 monitaring for frequently relapsing nephrotic syndrome in children: A randomized controlled trial
- Frequently relapsing nephrotic syndrome in children
- Japanese Study Group of Kidney Disease in Children
- 2005-08-01
Other
- DIAbetes and diffuse coronary Narrowing Analysis Study
- Patients with impaired fasting glucose or type-2 diabetes mellitus, who had coronary artery diseases
- National Cardiovascular Center
- 2005-09-01
Other
- Discontinuation of infliximab therapy after acquisition of low disease activity by infliximab in rheumatoid arthritis study: RRR (remission induction by remicade) study
- rheumatoid arthritis
- University of Occupational & Environmental Health, Japan
- 2009-06-23
Other
- Docetaxel and S-1 as adjuvant chemotherapy for pathological stage II, IIIA, IIIB gastric cancer
- Pathological stage II, IIIa, or IIIb gastric cancer
- Dept. of Surgery and Science, Kyushu University
- 2007-10-19
Other
- Docetaxel in combination with either cisplatin (DC) or gemcitabine (DG) in unresectable non-small sell lung carcinoma (NSCLC)
- Non-small sell lung carcinoma (NSCLC)
- The Tokyo cooperative oncology group
- 2006-01-23
Other
- Docetaxel(D) versus docetaxel plus gemcitabine(DG) for second-line treatment of non-small cell lung cancer (NSCLC) : Results of a JCOG randomized trial (JCOG0104)
- Non-small cell Lung Cancer
- Japan Clinical Oncology Group(JCOG)
- 2005-07-22